Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types
Year: 2024
Type: article
Source: The Lancet Oncology
Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Queen Mary University of London, Barts Cancer Institute, Memorial Sloan Kettering Cancer Center, Université Paris-Saclay, Institut Gustave Roussy, Centre Hospitalier Universitaire Vaudois, Dana-Farber Brigham Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404030460